Our Doctors
Best team gathered to provide premium quality.
Prof. Amr Abdelaziz
Professor of Clinical Oncology
- Professor of Clinical Oncology, Alexandria University
- Consultant Clinical Oncologist, Alexandria University Hospitals
- Co-Founder, SUN Oncology Center
- Co-Founder, Egybiotech Research
- MBChB of Medicine - Faculty of Medicine, Alexandria University (1979-1985)
- Master's Degree of Oncology - Faculty of Medicine, Alexandria University (1987-1990)
- Doctorate Degree at Radiotherapy and Oncology - Faculty of Medicine, Alexandria University (1992-1996)
Doctoral Clinical Research Fellowship in Stanford University, Department of Radiation Oncology 1994-1996. Doctorate degree thesis done at Stanford under the supervision of Professor Dr. J. Martin Brown, dealing with Radiation response modifier in cancer.
- Summer 1981 Universsitia di Pisa, Dipartimento di Radioterapia, Italy.
- Summer 1983 Buffalo General hospital, Department of Clinical Cardiology, Buffalo, NY USA.
- Professor of Clinical Oncology , Alexandria University (current)
- Consultant Clinical Oncology, Alexandria University Hospitals (current)
- Associate Professor in Clinical Oncology, Alexandria University
- Lecturer in Clinical Oncology, Alexandria University
- Fellow, Stanford University
- Assistant lecturer in Clinical Oncology, Alexandria University
- Resident in Clinical Oncology, Alexandria University Hospitals
- House officer, Alexandria University Hospitals
Membership of Advisory Boards and Professional Committees.
Prof. Amr currently sit on the advisory board of several local, national and multinational organizations including Eli- Lilly, Roche, Boehringer Ingelheim and Astrazeneca.
Membership of Professional Societies & Social organizations
- American Society of Radiation Oncology (Active member)
- American Society of Clinical Oncology (Active member)
- Egyptian Society of Radiology
- Egyptian Cancer Society
- Egyptian Society of Pediatric Oncology
- Mediterranean Rotary
Received a Merit Award from the UICC
(International Union Against Cancer) Ý (UICC) Ýon. The awarded project dealing with the frameless cyberknife stereotactic irradiation in primary and metastatic brain tumor. The project was hosted in Stanford University at the department of Radiation Oncology.
Received a Merit Award for the best presentation in, ICRO’97, June 5-7, 1997, Beijing, China.
“Radiation Response Modifier in Bilharzial Bladder Cancer"
Received a Merit Award from the American Society of Clinical Oncology
(ASCO) at the 1996 Annual Meeting (Philadelphia)